CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | HASTINGS DAVID C Chief Financial Officer | Sale 10b5-1 | −22,183 | $3.28 | $73K | 159,724 |
| 2025-02-04 | Sims Karen Chief Medical Officer | Sale 10b5-1 | −19,348 | $3.28 | $64K | 106,194 |
| 2025-02-04 | McElhaugh Michael J. Interim President & CEO | Sale 10b5-1 | −23,790 | $3.28 | $78K | 1,481,003 |
| 2025-02-04 | Naftzger J. Christopher General Counsel and CCO | Sale 10b5-1 | −11,333 | $3.28 | $37K | 86,244 |
| 2024-08-14 | MANCHESTER KEITH S Director | Sale | −8,846 | $3.69 | $33K | 46,069 |
| 2024-02-02 | Sims Karen Chief Medical Officer | Sale 10b5-1 | −4,358 | $2.31 | $10K | 125,542 |
| 2024-02-02 | HASTINGS DAVID C Chief Financial Officer | Sale 10b5-1 | −9,593 | $2.31 | $22K | 181,907 |
| 2024-02-02 | Sofia Michael J. Chief Scientific Officer | Sale 10b5-1 | −9,982 | $2.31 | $23K | 1,485,121 |
| 2024-02-02 | McElhaugh Michael J. Interim President & CEO | Sale 10b5-1 | −10,164 | $2.31 | $24K | 1,504,793 |
| 2021-12-01 | Sofia Michael J. Chief Scientific Officer | Sale | −200,000 | $5.09 | $1.0M | 1,303,403 |
| 2021-02-09 | McElhaugh Michael J. Chief Business Officer | Sale | −20,000 | $5.00 | $100K | 1,307,457 |
| 2020-12-14 | McElhaugh Michael J. Chief Business Officer | Sale | −30,000 | $5.00 | $150K | 1,337,457 |
| 2020-12-14 | McElhaugh Michael J. Chief Business Officer | Sale | −10,000 | $5.00 | $50K | 1,327,457 |
| 2020-07-23 | McElhaugh Michael J. Chief Business Officer | Sale | −20,000 | $5.01 | $100K | 1,367,457 |
Page 1 of 1 · 14 trades